Global ICON survey shows need for more efficient obesity clinical trial design to realise full potential of next-gen multi-indication therapies ICON plc, (NASDAQ: ICLR) a world-leading clinical ...

Rose Kidd, President, Global Operations Delivery at ICON, noted: "The considerable logistical and statistical expertise needed to collect longitudinal data and generate RWE may help explain why ...